Vicinitas Therapeutics specializes in developing protein stabilization platforms that can be used in therapeutics for cancer and genetic disorders, according to a July 28 news release from the biotechnology company.
Vicinitas Therapeutics founder Daniel K. Nomura, PhD stated he was excited about the potential for developing “novel therapies against therapeutic targets that were previously deemed undruggable and will respond to protein stabilization.”
A16z and Deerfield Management led the fundraising round with participation from GV.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
